Hemogenyx Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 6, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	46	35	14	27	13	18
Market Cap Growth	509.76%	143.47%	-47.51%	108.28%	-29.33%	-56.10%
Enterprise Value	47	36	15	27	7	9
Last Close Price	6.80	5.72	4.05	9.20	5.30	7.50
PB Ratio	40.40	30.19	16.63	9.72	4.00	2.25
P/TBV Ratio	45.63	34.10	33.78	11.51	4.58	2.37
Debt / Equity Ratio	1.75	1.75	3.07	1.06	1.06	0.00
Net Debt / Equity Ratio	0.37	0.37	2.89	0.61	0.27	-0.84
Net Debt / EBITDA Ratio	-0.06	-0.06	-0.48	-0.27	-0.16	2.61
Net Debt / FCF Ratio	-0.12	-0.12	-0.59	-0.27	-0.27	2.09
Quick Ratio	1.38	1.38	0.14	1.69	3.40	19.41
Current Ratio	1.38	1.38	0.72	2.93	3.47	20.23
Return on Equity (ROE)	-977.72%	-977.72%	-309.56%	-222.31%	-69.88%	-112.98%
Return on Assets (ROA)	-103.92%	-103.92%	-65.14%	-61.24%	-44.28%	-30.20%
Return on Capital Employed (ROCE)	-257.70%	-257.70%	-176.10%	-120.50%	-87.20%	-33.10%
Earnings Yield	-21.11%	-28.24%	-39.59%	-24.75%	-30.65%	-27.76%
FCF Yield	-7.47%	-9.99%	-29.26%	-23.02%	-25.72%	-17.77%
Buyback Yield / Dilution	-73.29%	-73.29%	-16.95%	-15.25%	-26.59%	-86.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.